LONDON (dpa-AFX) - British drug major AstraZeneca (AZN.L, AZN) Friday announced that its unit focused on rare diseases, Alexion Pharmaceuticals, Inc., is discontinuing CHAMPION-ALS, the global
M&S raises expectations as its food halls flourish, the bidding war for Morrisons takes another turn, AstraZeneca’s new potential coronavirus drug proves effective, and OSB grows cautiously confident as the economy recovers.
AstraZeneca s Alexion halts ALS trial on lack of efficacy reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.